Epithelial ovarian cancers (EOCs) constitute 90% of all ovarian cancers, and CA-125 (Cancer Antigen-125), a serum marker, is detected to be high in the blood in 80–90% of patients with advanced stage epithelial ovarian cancer [6]. This evidence concerns the gene MUC16 and ovarian cancer.